Clinical Trial Update: Study of Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone (CHOP) With Ofatumumab in Patients With Richter's Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating CHOP chemotherapy with ofatumumab for Richter's syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Richter Syndrome

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Hydroxydaunorubicin (doxorubicin)
• Ofatumumab (ofatumumab)
• Oncovin (vincristine)
• PREDNISONE (Prednisone)

Snippet

Sponsor: University of Oxford | Conditions: Richter's Syndrome | Phase 2 | Status: COMPLETED